Heterologous down-regulation of histamine H 1 receptor (H1R) mediated by muscarinic acetylcholine receptor subtype was investigated using five kinds of Chinese hamster ovary (CHO) cells stably co-expressing the human H1R and one of the five (M 1 -M 5 ) muscarinic acetylcholine receptors, CHO-H1/ M1, CHO-H1/ M2, CHO-H1/ M3, CHO-H1/ M4, and CHO-H1/ M5 cells. Among the CHO-H1/ M1, CHO-H1/ M3, and CHO-H1/ M5 cells, carbachol treatment of the CHO-H1/ M3 cells time-dependently led to remarkable down-regulation of the H1R to 60% of the control level. In contrast, stimulation of CHO-H1/ M1 cells by carbachol induced negligible effect on the down-regulation. Stimulation of CHO-H1/ M5 cells by carbachol induced significant but only small H1R down-regulation. M 2 and M 4 muscarinic receptors showed negligible effect on the down-regulation. H1R-mediated accumulation of inositol phosphates in CHO-H1/ M3 cells with long-term expose to carbachol was decreased to 60% compared with non-treated cells. Heterologous phosphorylation of H1R was induced by the stimulation of each muscarinic receptor. H1R was phosphorylated by about twofold from the basal level through five subtypes of muscarinic receptor. The M 3 muscarinic receptor-mediated phosphorylation of H1R was reversed by the inhibition of protein kinase C. In the present study we demonstrated that the M 3 muscarinic acetylcholine receptor mediated remarkable down-regulation of the H1R with decreased receptor signaling.
Introduction
The histamine H 1 receptor (H1R), one of the G protein-coupled receptors (GPCRs), predominantly couples with Gq / 11 protein and phospholipase C-b and mediates type I allergy in peripheral tissues and histaminergic neurotransmission in the central nervous system (1, 2) . Desensitization of various GPCRs including H1R has been documented and is thought to be a protection mechanism of receptor-bearing cells against excess stimulation. Two types of desensitization, homologous and heterologous desensitizations, have been extensively investigated by pharmacological methods. There are many reports about heterologous desensitization between different GPCRs. It is generally accepted that receptor phosphorylation is involved in receptor desensitization (3, 4) . Phosphorylation of GPCRs by second messenger-dependent protein kinases was postulated to trigger receptor desensitization. G-protein coupled receptor kinases (GRKs) were found to function in homologous desensitization.
Receptor desensitization has been considered to advance in three steps, namely, uncoupling with effectors, internalization, and down-regulation, as determined by studies at the molecular level. Down-regulation of GPCRs, which is thought to lead to long-term suppression of the receptor signaling, has been focused on with great interest (5 -7) . Long-term homologous stimulation of H1R by histamine also induced H1R downregulation (8) , and heterologous up-regulation of H1R by b 2 -adrenergic receptor activation was reported (9) . Down-or up-regulation of GPCRs alters the receptor function by regulation of receptor signaling. Previous study in human of type I allergy revealed that the number of H1R was changed (10) , which is of importance in its treatment.
Muscarinic receptors are distributed in various tissues, such as smooth muscle, cardiac muscle, and brain (11, 12) , and regulate numerous biological actions. The M 1 , M 3 , and M 5 muscarinic receptors couple predominantly to Gq-protein and activate phospholipase C, while M 2 and M 4 muscarinic receptors couple to Giprotein and inhibit adenylyl cyclase. H1R and each subtype of muscarinic receptors are co-expressed in various tissues. Especially, in regulation of airway smooth muscle contraction, these receptors are postulated to cross-talk with each other. The M 1 muscarinic receptor is localized to parasympathetic ganglia in pulmonary autonomic nerves in humans. The M 2 muscarinic receptor exists in post-ganglionic cholinergic nerves and both M 3 muscarinic and histamine H 1 receptors are co-localized on airway smooth muscle. Heterologous regulation of H1R signaling by muscarinic receptors via the parasympathetic nervous system is postulated to have physiological importance in the airway.
In the present study, we report M 3 musucarinic receptor-induced down-regulation of H1R, leading to a long-term regulation of H1R signaling mediated by some mechanism other than H1R phosphorylation.
Materials and Methods

Materials
Plasmid Preparation of CHO cells stably co-expressing the human H1R and each muscarinic acetylcholine receptor subtype CHO cells stably expressing H1Rs (CHO-H1R cells)
were prepared according to the previously described method (13) . Plasmids encoding muscarinic receptor subtype cDNAs were transfected into CHO-H1R cells. In brief, the mammalian expression vector pdKCR-dhfr, containing the wild-type human H1R gene was introduced into CHO cells with the calcium phosphate precipitation method. Transfected CHO cells were cultured in a -minimum essential medium without ribonucleosides and deoxyribonucleosides, and the CHO cell stably expressing the recombinant H1R was cloned. Then, the pcDNA3.1/ Zeo (+) vector (Promega K.K., Tokyo) encoding one of the M 1 -M 5 muscarinic receptor subtypes was transfected into CHO-H1R cells using PolyFect Transfection Reagent. CHO-H1R cells stably expressing one of the M 1 -M 5 muscarinic receptor subtypes (CHO-H1/ M1, CHO-H1/ M2, CHO-H1/ M3, CHO-H1/ M4, CHO-H1/ M5 cells) were cloned from individual colonies cultured in a -minimum essential medium without ribonucleosides and deoxyribonucleosides, containing 350 m g / ml zeocin. Cloned cells were cultured in a -minimum essential medium containing 150 m g / ml zeocin. CHO cells stably co-expressing human H1R and one of the muscarinic acethylcholine receptors were cultured at 37°C in a humidified incubator with 95% air and 5% CO 2 . CHO cells stably co-expressing c-myc-tagged human H1R and one of the muscarinic acethylcholine receptors were prepared by the same methods except using the mammalian expression vector pdKCR-dhfr, containing c-myc-tagged wildtype human H1R gene.
Assessment for H1R down-regulation
Receptor-bearing CHO cells incubated with 1 mM carbachol for 24 h and appropriate times were subjected to the [ 3 H]mepyramine binding assay. The cells were pretreated with atropine or protein kinase inhibitors 30 min prior to the stimulation with carbachol.
Membrane preparation and radioligand binding assay
Cultured cells grown to 80% confluency in 100-mm dishes or 150-mm dishes were harvested with a cell scraper into 1.5 ml of ice-cold 50 mM Na 2 / K-phosphate buffer (378 mM Na 2 HPO 4 , 122 mM KH 2 PO 4 , pH 7.4). Then the cell suspension was homogenized with an ultrasonic disrupter, and the homogenate was centrifuged at 18,000 rpm for 30 min. The pellet was resuspended in 50 mM Na 2 / K-phosphate buffer using the ultrasonic disrupter and served for the radioligand binding assay as the membrane sample. The [ 3 H]QNB and [ 3 H]mepyramine binding assays were performed according to the described methods (5, 13) . In brief, [ 3 H]mepyramine binding assay was carried out by the incubation of membranes with [ 3 H]mepyramine (0.1 -8 nM) in the absence or presence of 10 m M triprolidine at 25°C for 60 min in a final volume of 500 m l. [ 3 H]QNB binding assay was performed by the incubation of membranes with [ 3 H]QNB (0.01 to 2 nM) in the absence or presence of 10 mM atropine at 37°C for 60 min in a final volume of 500 ml. Assays were terminated by rapid vacuum filtration through Whatman GF / B filters. Filters were soaked in 10 ml of Aquasol-2, and then the radioactivities trapped on the filters were counted in a liquid scintillation counter.
Western blotting
CHO cells stably co-expressing c-myc-tagged human H1Rs and m 3 muscarinic receptors (CHO-c-myc-H1/ M3 cells) were harvested in ice-cold TE (10 mM Tris-HCl / 2.5 mM EDTA) containing 1 mM sodium orthovanadate, 100 mg / ml benzamidine, and 1 mM phenylmethylsulfonyl fluoride at scheduled times and then centrifuged at 500´g for 5 min after ultrasonic cell disruption. The supernatant was then recentifuged at 15,000´g for 15 min. The resultant crude membrane pellet was resuspended in SDS sample buffer [50 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.005% bromophenol blue] by using the ultrasonic disrupter. Protein concentrations were determined by using a Bio-Rad assay kit with bovine serum albumin as the standard. Cell extracts containing 50 m g of protein in each sample were ultrasonically disrupted and served for electrophoresis using an 8% SDS polyacrylamide gel. After electro-blotting onto nitrocellulose filters, the filters were stained with Ponceau S to ensure quantitative transfer of proteins. The membranes were first blocked for 2 h at room temperature with 5% skim milk. Then, the blots were incubated for 2 h at room temperature with primary antibody (mouse monoclonal anti-c-myc), which was followed by incubation for 2 h with secondary antibody (horseradish peroxidase-conjugated anti mouse IgG). Immunoreactive bands were visualized by chemiluminescence using the ECL Western Blotting Detection System (Amersham, UK).
Phosphorylation of H1R in CHO cells
Cells grown to 60% confluency in 100-mm dishes were washed with phosphate-free Dulbecco's modified Eagle's medium (DMEM) and then incubated in the same medium containing [ 32 P]orthophosphate (50 m Ci / ml) for 2 h at 37°C. Metabolically labeled cells were incubated with 100 mM histamine for 5 min or with different concentrations of carbachol for varying lengths of time. To study the effects of some drugs on H1R phosphorylation, cells were pretreated with drugs for 30 min before adding carbachol, and treatment was continued through the incubation with carbachol. After treatment, cells were washed three times with ice-cold Ca 2+ , Mg 2+ -free phosphate-buffered saline (PBS(-)); lysed with 1 ml of solubilizing buffer (20 mM Tris-HCl, pH 7.4, containing 137 mM NaCl, 2 mM EDTA, 1% NP-40, 20 mM NaF, 5 m g / ml leupeptin, 5 m g / ml soybean trypsin inhibitor, and 10 m g/ ml benzamidine); drawn through a 26-gauge needle 10 times; and rotated at 4°C for 30 min. After centrifugation at 15,000 rpm for 30 min, the supernatants were collected. The solubilized receptors were immunoprecipitated with 5 m l of anti-c-myc (9E10) conjugated to protein A / G plus agarose during a 2-h rotation at 4°C. The beads were collected by centrifugation (20,000´g, 1 min) and washed three times by solubilizing buffer. Phosphorylated receptors were eluted with SDS sample buffer and resolved by 8% SDS-PAGE. Phosphorylated proteins were electrophoretically transferred onto a nitrocellulose filter and visualized by using a BAS-1500 Fuji Bioimage analyzer (Fuji Film Co., Tokyo). To confirm the position of H1R in the autoradiogram, Western blot analysis using anti-c-myc antibody was also performed as described above.
Measurement of inositol phosphates (IPs) and phosphatidylinositol 4,5-bis phosphate (PIP 2 )
CHO-H1/ M3 cells were cultured in a 12-well culture plate and labeled with myo-[ 3 H]inositol at 37°C for 24 h with or without 1 mM carbachol. Then the labeled cells with myo-[ 3 H]inositol were washed three times in HEPES buffered saline (HBS: 125 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl 2 , 1.2 mM KH 2 PO 4 , 15 mM NaHCO 3 , 11 mM glucose, 10 mM LiCl, and 15 mM HEPES, pH 7.4) and then incubated for several times in HBS containing 100 mM histamine at 37°C. The reaction was terminated by addition of 5% trichloroacetic acid. Total [ 3 H]IPs was isolated by anion exchanger choromatography using AG1-X8, 100 -200 mesh, and radioactiveties were determined. PIP 2 was determined as described previously (14) .
Statistical analysis
All data except for those in Fig. 4 are expressed as means ± S.E.M. of at least three independent experiments. Statistical analysis was carried out by Student's t-test. P values <0.05 were considered statistically significant.
Results
Down-regulation of H1Rs mediated by muscarinic acetylcholine receptor subtypes
To investigate the H1R down-regulation mediated by each muscarinic acetylcholine receptor subtype, five kinds of CHO cells stably co-expressing H1R and one of the muscarinic acetylcholine receptor subtypes (CHO-H1/ M1, CHO-H1/ M2, CHO-H1/ M3, CHO-H1 / M4, CHO-H1/ M5 cells) were prepared. H1Rs and muscarinic receptor subtypes expressed in these CHO cells were characterized by radioligand binding assays using [ 3 H]mepyramine and [ 3 H]QNB, respectively; and CHO cells expressing H1Rs with B max values ranging from 2.2 to 2.8 pmol / mg protein and muscarinic receptor subtypes with B max values ranging 1.0 to 2.8 pmol / mg protein were selected for further experiments (Table 1 ). Heterologous down-regulation of H1Rs was induced in CHO-H1/ M3 and CHO-H1/ M5 cells among five kinds of CHO cells 24 h after the stimulation by 1 mM carbachol ( Fig. 1 ). H1Rs were down-regulated to 60% of the initial level in CHO-H1/ M3 cells. Downregulation of H1Rs in CHO-H1/ M5 cells was 20% of the control during the same time course. No obvious down-regulation was induced in CHO-H1/ M1, CHO-H1/ M2, and CHO-H1/ M4 cells. The down-regulation of H1R in CHO-H1/ M3 cells was completely blocked by the pretreatment with 10 mM atropine ( Fig. 2 ). All drugs we used for determining H1R density did not alter the K d values of [ 3 H]mepyramine binding ( Table 2) . Time-and dose-dependent decrease in [ 3 H]mepyramine binding to CHO-H1/ M3 cell membranes was induced by carbachol ( Fig. 3: A and B ). Decrease in [ 3 H]mepyramine binding was induced at least by 100 nM carbachol. Treatment of either 1 mM carbachol for 18 h or 100 mM carbachol for 24 h induced maximum decrease in H1Rs at 60% of the initial level. Stimulation by the combination of 100 m M histamine and 1 mM carbachol for 24 h induced a decrease in [ 3 H]mepyramine binding to 70% of the control (Fig. 3A) . The decrease induced by histamine plus carbachol was larger than that by either carbachol or histamine alone.
Immunodetection of H1R down-regulation mediated by the M 3 muscarinic receptor
In order to confirm the heterologous H1R downregulation mediated by the M 3 muscarinic receptor, immunoblot analysis was performed. The band of approx. 60 kd corresponding to c-myc-tagged H1Rs was successfully immuno-detected in CHO-c-myc-H1/ M3 cells using an anti-c-myc antibody (Fig. 4) . Remarkable down-regulation of c-myc-tagged H1Rs was induced by the treatment of 1 mM carbachol for 24 h. The downregulation was completely reversed by the pretreatment of atropine (Fig. 4) . Attenuation of histamine-induced IPs accumulation through down-regulated H1Rs mediated by M 3 muscarinic receptors Stimulation of histamine induced 30-fold increase in IPs accumulation in CHO-H1/ M3 cells (Fig. 5 ). After the exposure of CHO-H1/ M3 cells to 1 mM carbachol for 24 h, histamine-induced accumulation of IPs in the cells was about 20-fold over the control. Basal lipid labeling of CHO-H1/ M3 cells and basal IPs accumulation was not altered by the pretreatment with carbachol (data not shown).
Phosphorylation of H1R mediated by muscarinic receptors
Treatment with 100 m M histamine to CHO-H1/ M3 cells caused homologous phosphorylation of H1R; the phosphorylated H1R was increased about eightfold from the basal level (Fig. 6A ). Carbachol-induced heterologous phosphorylation of H1R was twofold higher than the basal level. Stimulation of each subtype The mean initial values of IPs accumulation were 487 ± 21 dpm /well in control cells and 520 ± 38 dpm /well in cells pretreated with carbachol, and values of IPs accumulation were expressed as folds of the mean initial ones. Data are from 4 independent assays in duplicate. *P<0.01, significant difference from the control cells. (M 1 -M 5 ) of muscarinic receptors induced phosphorylation of H1Rs (Fig. 6B ). Levels of phosphorylation were similar (about twofold of the control) by the stimulation of M 1 , M 2 , and M 3 muscarinic receptor subtypes and lower (about 1.6-fold of the control) by the stimulation of M 4 and M 5 muscarinic receptor subtypes. Phosphorylation levels of the two groups were significantly different.
Effect of PKC inhibitor on H1R phosphorylation and H1R down-regulation mediated by M 3 muscarinic receptors Stimulation by 1 mM carbachol induced remarkable phosphorylation of H1Rs in CHO-H1/ M3 cells (twofold increase from the basal level, Fig. 7) . The phosphoylation of H1R was completely reversed by the pretreatment of 10 m M atropine, but not pretreatment of 10 mM diphenhydramine. This heterologous phosphorylation of H1Rs was completely inhibited by 10 m M Ro 31-8220, an inhibitor of PKC. In contrast, carbachol-induced H1R down-regulation in CHO-H1/ M3 cells was not significantly affected by the pretreatment of 5 mM Ro 31-8220 (Fig. 8) . The treatment of Ro 31-8220 alone was without effect. In spite of pretreatment with Ro 31-8220, H1R was down-regulated by carbachol at the concentrations of 10, 100, and 1,000 mM for 24 h to 70%, 68%, and 63% of the control, respectively.
Effect of PKG inhibitor on H1R phosphorylation and H1R down-regulation mediated by M 3 muscarinic receptors
We previously reported that histamine-induced homologous down-regulation of H1R was inhibited by Fig. 7 . Effect of M3 receptor antagonist, PKC inhibitor, and histamine H1 receptor antagonist on M3 muscarinic receptormediated H1R phosphorylation. Metabolic labeling of CHO-H1/M3 cells was performed with [ 32 P]orthophosphate. Labeled cells pretreated with 10 m M atropine, 5 m M Ro 31-8220, or 10 m M diphenhydramine for 30 min were incubated with 1 mM carbachol for 5 min. Solubilization of the cells was performed, and solubilized receptors were immuno-precipitated with anti c-myc antibody. The precipitated receptors were subjected to SDS polyacrylamide gel elecrophoresis, and detection of phosphrylated receptors was performed by radioautography. Graph shows the cumulative data and the gels shown are representative of 3 experiments. *P<0.01, significant difference from the control cells. **P<0.01, significant difference from carbachol-treated cells the pretreatment with KT5823, a PKG inhibitor (15) . Thus we examined the effect of KT5823 on M 3 muscarinic receptor-mediated H1R down-regulation. CHO-H1/ M3 cells pretreated with 3 m M KT5823 for 30 min were stimulated by carbachol at concentrations of 10, 100, and 1,000 m M. KT5823 showed no inhibitory effect on the M 3 muscarinic receptor-mediated H1R down-regulation. M 3 muscarinic receptor-mediated H1R down-regulations in CHO-H1/ M3 cells pretreated with KT5823 were similar to those without any pretreatment ( Fig. 9 ). Stimulation of carbachol at concentrations of 10, 100, and 1,000 m M for 24 h induced decreases in H1R levels by 30%, 34%, and 32% of the initial levels, respectively, in CHO-H1/ M3 cells pretreated with KT5823.
Discussion
In this study, we have clearly demonstrated H1R down-regulation mediated by M 3 and M 5 muscarinic receptors ( Fig. 1 ). H1R down-regulation mediated by M 3 muscarinic receptors was also successfully confirmed by Western blot analysis (Fig. 4) . Antagonism by atropine of the H1R down-regulation either by [ 3 H]mepyramine binding assay (Fig. 2) or by Western blot analysis ( Fig. 4) clearly demonstrates the heterologous down-regulation mediated by the muscarinic receptor. Although M 1 , M 3 , and M 5 muscarinic receptors are all GPCRs predominantly coupling with Gq / 11 and phospholipase C-b, the M 3 receptor was the strongest among them for the induction of H1R down-regulation. The H1R down-regulation was weakly induced by the stimulation of the M 5 receptor and little observed by the stimulation of the M 1 receptor. The molecular mechanisms of heterologous H1R down-regulation induced by M 3 and M 5 muscarinic receptors remain to be elucidated. H1Rs and M 3 muscarinic receptors are co-localized in various smooth muscles in peripheral tissues and in the central nervous system, for example, in the airway smooth muscle and brain cortex (2, 11) . The downregulation may play an important role in H1R-mediated histamine functions in these tissues.
The H1R down-regulation by M 3 receptors was induced in dose-and time-dependent manner (Fig. 3) . It took 18 h to reach the maximum with 40% reduction of the initial level. In contrast, the homologous H1R down-regulation mediated by H1R proceeded over 24 h with 60% reduction of the initial level. Combination of histamine and carbachol showed a larger effect than each alone on H1R down-regulation. The results suggest that the mechanism of the heterologous H1R downregulation is different from that of the homologous H1R down-regulation. It is also supported by the result that KT5823, a PKG inhibitor, reduced the homologous down-regulation (15) , but not the heterologous one at all ( Fig. 9 ).
H1R-mediated accumulation of IPs was decreased corresponding to the H1R down-regulation by M 3 muscarinic receptors in CHO-H1/ M3 cells (Fig. 5 ). Similar decrease in IPs accumulation due to b 2 -receptormediated H1R down-regulation was also documented (16) . It was also observed that phorbol 12-myristate 13acetate (PMA), a PKC-activating phorbol ester, induced H1R up-regulation, and H1R-mediated IPs accumulation was increased correspondingly. These results strongly suggest that H1R-mediated signaling is regulated by the expression level of H1R. The activation of M 3 receptors may induce the reduction of H1R-mediated histamine signaling in vivo. Especially, H1R-mediated reaction in type I allergy may be strongly regulated by the autonomic parasympathetic system. Autonomic regulation of H1R-mediated reaction in type I allergy was reported in another report (9) . Long-term use of b 2agonist in bronchial asthma is linked to the development of bronchial hyper-responsiveness due to the downregulation of b 2 -adrenergic receptor (17) and also caused up-regulation of airway smooth muscle H1R mRNA and protein.
It has been generally accepted that phosphorylation of GPCRs is a key event in their desensitization. However, it has not been elucidated whether H1R phosphorylation is involved in the H1R down-regulation. The H1R was homologously phosphorylated in vivo ( Fig. 6) and was phosphorylated in vitro by several protein kinases including PKC and protein kinase A (18) . In this report, we showed that H1R was heterologously phosphorylated by the activation of each subtype of muscarinic receptor in five kinds of CHO cells (Fig. 6B) . The phosphorylation of H1R by M 3 muscarinic receptors was rapid but transient. Carbachol-induced H1R phosphorylation by M 3 muscarinic receptor activation occurred after 30-s stimulation and returned to the basal level in 40 min (data not shown). The level of phosphorylation mediated by M 3 muscarinic receptors was far weaker than that mediated by H1Rs. Histamine increased H1R phosphorylation by eightfold from the basal level, while carbachol induced H1R phosphorylation by about twofold ( Fig. 6A ). H1R phosphorylation mediated by M 3 muscarinic receptors was completely inhibited by Ro 31-8220 ( Fig. 7 ), suggesting that this small amount of H1R phosphorylation was solely catalyzed by PKC.
A recent report has shown that H1R lacking putative phosphorylation sites was not down-regulated by histamine, suggesting that phsophorylation of H1R is the key step in homologous down-regulation of H1R (19) . However, the heterologous down-regulation of H1R by M 3 muscarinic receptors seems not to be involved in HR phosphorylation because the down-regulation was still induced in the presence of Ro 31-8220 when H1R phosphorylation was completely inhibited. KT5823, a PKG inhibitor, was without effect on M 3 muscarinic receptor-mediated heterologous H1R down-regulation, although the compound showed partial inhibition of homologous H1R down-regulation (15) . Recently, there have been many reports about dimerization of GPCRs. Adrenergic a 2a and b 1 receptors heterodimerize and stimulation of adrenergic a 2a receptor causes internalization of adrenergic b 1 receptor (20) . Heterodimerization of somatostatin and opioid receptors crossmodulate their pharmacological properties (21) . Thus H1R and some muscarinic receptor subtypes (especially H1R and M 3 muscarinic receptors) may heterodimerize, and cause heterologous down-regulation of H1R. The physiological significance of M 3 muscarinic receptormediated heterologous H1R phosphorylation remains to be elucidated.
In conclusion, heterologous down-regulation of H1R was induced by the stimulation of M 3 and M 5 muscarinic receptors and resulted in a decrease in H1R-mediated signaling. The heterologous H1R phosphorylation catalyzed by PKC seemed not to be involved in heterologous H1R down-regulation. H1Rs and M 3 muscarinic receptors are co-located in various peripheral tissues including smooth muscles, vascular endothelial cells, and the central nervous system. The heterologous downregulation of H1Rs is hypothesized to play important physiological and pathophysiological roles in peripheral tissues under parasympathetic regulation and in the central nervous system.
